Facebook
Twitter
Telegram
Report an ErrorAcorda Therapeutics Cash Flow 2011-2024 | ACOR
Annual Cash Flow Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-14 M | -20.9 M | -41.3 M | -61 M | -128 M | 151 M | 97.1 M | 29.6 M | - | - | - | - | 66.3 M |
Depreciation & Amortization |
31.7 M | 32.8 M | 34 M | 41.3 M | 34.6 M | 11.5 M | 23.2 M | 21.6 M | 15 M | 8.47 M | 7 M | 4.66 M | 4.62 M |
Accounts Payables |
13.4 M | 9.81 M | 10.8 M | 12.2 M | 26.3 M | 48.9 M | 27.4 M | 26.9 M | 14.2 M | 17.8 M | 15.9 M | 22.5 M | 21.4 M |
Accounts Receivables |
17.3 M | 13.9 M | 17 M | 20.2 M | 22.1 M | 23.4 M | 81.4 M | 52.2 M | 31.5 M | 32.2 M | 30.8 M | 26.3 M | 22.8 M |
Total Inventories |
16.2 M | 12.8 M | 18.5 M | 28.7 M | 25.2 M | 29 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Acorda Therapeutics
| 2024-Q1 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-20.2 M | -7.02 M | - | -30 M | -28.2 M | -13.6 M | - | -44.6 M | -35.6 M | -26.9 M | - | -62.5 M | -59.5 M | -38.8 M | - | -117 M | -92.4 M | -77.5 M | - | 163 M | 85 M | 28.7 M | - | 36.6 M | -15.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -12.1 M |
Depreciation & Amortization |
882 K | 7.91 M | - | 24.8 M | 17 M | 8.53 M | - | 25.5 M | 17.2 M | 8.53 M | - | 30.9 M | 20.7 M | 10.1 M | - | 24.7 M | 14.9 M | 4.85 M | - | 9.12 M | 6.65 M | 3.31 M | - | 17.5 M | 11.7 M | 5.65 M | - | 15.8 M | 9.92 M | 3.95 M | - | 11.2 M | 7.49 M | 3.71 M | - | 5.38 M | 3.62 M | 1.76 M | - | 4.62 M | 2.91 M | 1.4 M | - | 3.05 M | 1.95 M | 912 K | - | 3.21 M | 2.18 M | 1.14 M |
Accounts Payables |
9.93 M | 2.85 M | 9.81 M | 11.5 M | 7.96 M | 8.77 M | 10.8 M | 15.5 M | 17.5 M | 9.49 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 26.3 M | 26.3 M | 26.3 M | 26.3 M | 48.9 M | 48.9 M | 48.9 M | 48.9 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 26.9 M | 26.9 M | 26.9 M | 26.9 M | 14.2 M | 14.2 M | 14.2 M | 14.2 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 15.9 M | 15.9 M | 15.9 M | 15.9 M | 22.5 M | 22.5 M | 22.5 M | 22.5 M | 21.4 M | 21.4 M | 21.4 M | 21.4 M |
Accounts Receivables |
9.19 M | 9.19 M | 13.9 M | 14.7 M | 14.3 M | 12 M | 17 M | 13.6 M | 14 M | 17.3 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 23.4 M | 23.4 M | 23.4 M | 23.4 M | 81.4 M | 81.4 M | 81.4 M | 81.4 M | 52.2 M | 52.2 M | 52.2 M | 52.2 M | 31.5 M | 31.5 M | 31.5 M | 31.5 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 30.8 M | 30.8 M | 30.8 M | 30.8 M | 26.3 M | 26.3 M | 26.3 M | 26.3 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M |
Total Inventories |
14.1 M | 13.5 M | 12.8 M | 15.3 M | 15.3 M | 14.8 M | 18.5 M | 20.6 M | 25.4 M | 27.4 M | 28.7 M | 28.7 M | 28.7 M | 28.7 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | 29 M | 29 M | 29 M | 29 M | 37.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency